InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-4.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Gray Mary Ann. Insider active across 5 companies, notably Sarepta Therapeutics, Inc.. Aggregated, 18 filings have been logged. Activity tracked since 10 December 2021. The latest transaction was disclosed on 30 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gray Mary Ann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
4,956 sharesCommon StockSEC:0001261974-26-000003:0
4,956 shares0Common StockSEC:0001261974-26-000002:0
23,500 shares0Common StockSEC:0000950170-25-088062:0
5,250 shares0Common StockSEC:0001415889-25-015974:0
16,500 shares0Common StockSEC:0000950170-24-073683:0
5,995 shares0Common StockSEC:0001209191-24-000601:0
8,676 shares0Common StockSEC:0001209191-23-051691:0
4,916 shares0Common StockSEC:0001209191-23-041218:0
5,503 shares0Common StockSEC:0001209191-23-029631:0
2,953 shares0Common StockSEC:0001209191-22-017352:0
967 shares0Common StockSEC:0001209191-21-069638:0
232,440 sharesCommon StockSEC:0000908662-16-000433:0
6,000 sharesCommon StockSEC:0000908662-16-000402:0
75,000 sharesCommon StockSEC:0000908662-16-000402:1
75,000 sharesCommon StockSEC:0000908662-16-000402:2
8,107 sharesCommon StockSEC:0000908662-16-000402:3
25,000 sharesCommon StockSEC:0000908662-16-000402:4
33,333 sharesCommon StockSEC:0000908662-16-000402:5
18 of 18 declarations
About Gray Mary Ann
GRAY MARY ANN is a declarant linked to DYAX CORP, BioAtla, Inc. and Sarepta Therapeutics, Inc., where she is listed as Director at BioAtla, Inc. and Sarepta Therapeutics, Inc. She has 15 filings in total, and across the 15 sampled filings the most frequent transaction nature is option exercise; the sampled filings span from 2016-01-19 to 2024-06-14.
